UnitedHealth Group (UNH) beat expectations in FY2026 on revenue of $130.2B versus the $126.5B estimate (-1.8% YoY) and EPS of $1.24. Below is the full UnitedHealth Group earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.
UnitedHealth Group (UNH) Earnings Analysis — key stats
Latest reported quarter
FY2026
Earnings verdict
Beat
Revenue
$130.2B (vs $126.5B est · +2.9% surprise · -1.8% YoY)
EPS
$1.24 (vs $1.20 est · +3.3% surprise · +30.9% YoY)
Share price
$209.65 (+1.9%)
Market cap
$690.0B
What you'll find
Next UnitedHealth Group (UNH) earnings date, the expected move and the estimates priced in
A clear Beat / Miss / In-line / Mixed verdict the moment UnitedHealth Group reports
Revenue & EPS versus estimates, guidance and segment trends
Multi-lens price forecast — analyst, quant, technical and options views
Deep research: red flags, risk decoder and earnings-call sentiment
Technicals, options / implied volatility and unusual-activity signals
Hedge-fund and legendary-investor 13F holdings in UnitedHealth Group (UNH)
Side-by-side peer and historical earnings comparison
Frequently asked questions
When is UnitedHealth Group's next earnings date?
Magnisto tracks UnitedHealth Group's (UNH) earnings schedule and shows the confirmed next earnings date, the options-implied expected move and the estimates analysts are modeling into the print.
Did UnitedHealth Group (UNH) beat or miss earnings?
In FY2026, UnitedHealth Group (UNH) posted beat results — revenue of $130.2B versus the $126.5B estimate (+2.9% surprise) and EPS of $1.24 versus $1.20 expected (+3.3% surprise). Magnisto decodes every UnitedHealth Group (UNH) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for UnitedHealth Group (UNH) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for UnitedHealth Group (UNH), anchored to the current $209.65 share price, so you can weigh the bull, base and bear cases for UnitedHealth Group side by side.
Is UnitedHealth Group (UNH) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether UnitedHealth Group fits your own thesis and risk profile. This is research, not investment advice.